Skip to Main Content

Why the Janssen/Johnson & Johnson Pause Should Make You Feel Safer

Thomas G. McGinn, MD, MPH System Executive Vice President, CommonSpirit Health

On Tuesday, April 13, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) jointly announced a recommendation to pause administration of the Janssen/Johnson & Johnson (J&J) vaccine as it undergoes further investigation for rare blood clotting events.

Publish date: 

Tuesday, May 25, 2021

News

CommonSpirit Supports 'Hospitals Against Violence' Initiative

JUN 02, 2023

As part of our mission to improve the lives and wellbeing of those who we serve, CommonSpirit Health is committed to addressing violence.

Read More Additional information about CommonSpirit Supports 'Hospitals Against Violence' Initiative

Two CommonSpirit hospitals launching chaplain shadowing program for seminarians

JUN 01, 2023

Through two new partnereships, CommonSpirit hospitals will host small cohorts of seminary students for six-week sessions.

Read More Additional information about Two CommonSpirit hospitals launching chaplain shadowing program for seminarians

CommonSpirit joins with Siemens to acquire radiology vendor

MAY 25, 2023

CommonSpirit Health has teamed up with Siemens Healthineers to acquire Block Imaging, a Michigan-based supplier of imaging parts and services.

Read More Additional information about CommonSpirit joins with Siemens to acquire radiology vendor